Publications

Export 6557 results:
Sort by: Author [ Title  (Desc)] Type Year
A B C D E F G H I J K L [M] N O P Q R S T U V W X Y Z   [Show ALL]
M
, "Myelodysplastic Syndrome: An Egyptian Experience", Blood Disorders & Transfusion, 2012. myelodysplasia.pdf
Dawoud, N. M., O. H. Ayoub, E. S. Essa, and D. M. Dawoud, "Myelodysplasia in a psoriasis patient receiving etanercept: Cause or coincidence?", Indian journal of dermatology, venereology and leprology, vol. 84, issue 4, pp. 463-465, 2018 Jul-Aug.
Ismail, Z. M. K., N. M. A. Amin, M. F. Y. Yacoub, and A. M. O. Mohamed, "Myelo-enhancement by astragalus membranaceus in male albino rats with chemotherapy myelo-suppression. Histological and immunohistochemical study.", International journal of stem cells, vol. 7, issue 1, pp. 12-22, 2014 May. Abstract

BACKGROUND AND OBJECTIVES: Myelosuppression is the most common toxicity encountered in the oncology clinic today. This study was planned to investigate the possible protective and therapeutic role of the traditional Chinese Medicinal Herb; Astragalus Membranaceus (AM), on chemotherapy-induced myelosuppression.

METHODS AND RESULTS: This study was carried out on thirty six adult male albino rats. They were divided into: Group I Control Group (n=6) received a vehicle of phosphate buffered saline (PBS) solution. Group II (n=12) were injected I.P. with cyclophosphamide (CY) for 3 days (gIIa n =6) and continued for one more week to receive AM orally (gIIb n=6). Group III (n=6) received CY I.P. together with AM orally for 3 days. Group IV (n=12) received AM orally for one week (gIVa n=6) and continued for extra three days receiving CY I.P. with AM orally (gIVb n=6). Blood samples were analysed for Total Leucocytic Count and Lymphocytic Count. Counting of CD34 +ve cells in bone marrow was performed by flowcytometry. Bone marrow sections were subjected to H&E stain as well as immunohistochemical staining for anti- CD20 antibody. The mean area % of cellular bone marrow regions occupied by developing haemopoietic cells, mean area of fat cells and mean number of CD20 immunopositive B lymphocytes in the bone marrow were measured by histomorphometric studies and statistically compared. AM proved to have a myelo-protective and myelo-therapeutic capacity, evidenced at both laboratory and morphological levels.

CONCLUSIONS: The greatest myelo-potentiating effect of AM was achieved when supplied before and together with CY therapy.

Ismail, Z. M. K., N. M. A. Amin, M. F. Y. Yacoub, and A. M. O. Mohamed, "Myelo-Enhancement by Astragalus Membranaceus in Male Albino Rats with Chemotherapy Myelo-Suppression. Histological and Immunohistochemical Study", International Journal of Stem Cells, vol. 7, issue 1, pp. 12-22, 2014.
Zaki, M. M., S. A. El-Midany, H. M. Shaheen, and L. Rizzi, "Mycotoxins in animals: Occurrence, effects, prevention and management", Journal of Toxicology and Environmental Health Sciences, vol. 4, no. 1: Academic Journals, pp. 13–28, 2012. Abstract
n/a
Rashad, Y. M., Z. A. M. Baka, and T. A. A. Moussa, "Mycotoxins and Their Producers: Diversity, Side Effects and Control", Plant Mycobiome: Diversity, Interactions and Uses: Springer, pp. 1 - 27, 2023. Abstract
n/a
Ben Hassouna, K., A. M. Hamed, J. B. Salah-Abbès, K. Chaieb, S. Abbès, A. M. García-Campaña, and L. Gámiz-Gracia, "Mycotoxin Occurrence in Milk and Durum Wheat Samples from Tunisia Using Dispersive Liquid–Liquid Microextraction and Liquid Chromatography with Fluorescence Detection", Toxins, vol. 15, no. 11, 2023. AbstractWebsite
n/a
El-Nabarawy, A. M., E. Ismael, K. A. Shaaban, S. E. S. Basuni, M. M. Batikh, and M. Shakal, "Mycotoxin Contamination Levels in Broiler Feeds and Aflatoxin Residues in Broiler Tissues.", J. World Poult. Res., vol. 10, issue 2S, pp. 133-144, 2020.
El-Nabarawy, A. M., E. Ismael, K. A. Shaaban, S. E. S. Basuni, M. M. Batikh, and M. Shakal, "Mycotoxin Contamination Levels in Broiler Feeds and Aflatoxin Residues in Broiler Tissues", J. World Poult. Res., vol. 10, issue 2S, pp. 133-144, 2020.
Refai, M., Hammad, H., Salem, N., A. El-Aziz, A., A. S., Azzam, and G. Edris, "Mycotic infections in birds and rabbits and their control. ", Vet. Med. J. , vol. 38, , pp. 129-143 , 1990. mycotic_infections_in_birds.pdf
El-Naggar, A., Ahmed, F. Ibrahim, and M. Refai, "Mycotic abortion in small ruminants induced by Aspergillus fumigatus in Egypt.. ", J. Comp. Pathol. & Clinc. Pathol., vol. 10, , pp. 59-76 , 1997. mycotic_abortion_in_small_ruminants_cause_by_a._fumigatus.pdf
Osman, K. M.,, Jouini R, Z. M. S. Amin, and B. S. Hasan, "Mycoplasma gallisepticum: an emerging challenge to the poultry industry in Egypt.2009.", . OIE - World Organisation for Animal Health Scientific and Technical Review, vol. 28, pp. 1015-1023, 2009.
Marouf, S., M. A. Khalf, M. Alorabi, A. M. El-Shehawi, A. M. El-Tahan, M. A. E. El-Hack, M. T. El-Saadony, and H. M. Salem, "Mycoplasma gallisepticum: a devastating organism for the poultry industry in Egypt.", Poultry science, vol. 101, issue 3, pp. 101658, 2022. Abstract

Mycoplasma gallisepticum (MG) is a worldwide ruined bacteria affecting different avian species, causing severe economic losses. Consequently, the current research sought to detect the incidence of MG among different commercial broiler, layer chickens and turkey farms, and environmental litter samples in different Egyptian governorates (Damietta, Giza, El-Qalyobia, El-Sharqia, and El-Behera) from January 2019 to December 2020. Four hundred samples (infraorbital sinus aspirates, tracheal swabs, serum from diseased birds, and organ samples; lung tissues, air sacs and tracheal bifurcation from freshly dead birds), and environmental samples (litter) were collected for MG isolation. Samples were subjected to phenotypic and molecular identification. Positive bacteriological samples were subjected for molecular identification using polymerase chain reaction (PCR) test to detect MG, then sequencing for PCR amplicon of mgc2 gene. Out of 332 samples subjected for bacteriological examination, 206 were bacteriologically positive for MG with an incidence of 62%. The highest incidence of MG was detected in turkey farms at a rate of 83%, followed by broiler chicken farms, layer chicken farms and litter samples at a percentage of 70, 40, and 40, respectively. The highest prevalence of MG in chickens and turkey was recorded during the winter and autumn seasons. Molecular identification of MG isolates revealed that 85% of isolates were positive for mgc2 gene using PCR. The Four sequenced strains in this study are closely related and placed in one group with the vaccine strain 6/85 and ts11 strain.

Fathy, M., H. A. - A. I. Mounir M. El-Safty, M. A. K. Mohamed A. Ibrahim, and J. K.El-Jakee, "Mycoplasma gallisepticum Infection and Efficacy of Inactivated Poultry Viral Vaccines", . Journal of Global Pharma Technology. 11(6S):145-154, vol. 11, issue 6S, pp. 145-154, 2019.
Osman, K., A. Orabi, M. mahdy, W. abd el azim, M. abo el makarem, and Z. roshdy, "Mycoplasma as a Major Pathogen of Respiratory Disease in Egyptian Cattle", Journal of global bioscience , vol. 4, pp. 2630-2635, 2015.
El-Darouti, M. A., M. M. Fawzy, I. M. Amin, R. M. Abdel Hay, R. A. HEGAZY, and D. M. ABDELHALIM, "Mycophenolate mofetil: a novel immunosuppressant in the treatment of dystrophic epidermolysis bullosa, a randomized controlled trial.", The Journal of dermatological treatment, vol. 24, issue 6, pp. 422-6, 2013 Dec. Abstract

BACKGROUND: No effective treatment has been found for epidermolysis bullosa dystrophica (EBD).

OBJECTIVE: To evaluate the efficacy and safety mycophenolate mofetil (MMF) in treating EBD.

METHODS: This randomized controlled double-blinded study included 35 patients with severe generalized EBD. Patients were randomly divided into two groups: group I (18 patients) received cyclosporine therapy (5 mg/kg/day) and group II (17 patients) received MMF therapy (500-1500 mg/day). Clinical assessment was made weekly for 3 months from the start of the treatment. Patients were assessed by measuring the extent of the disease, the % of improvement, assessing the number of new blister formation and the time of complete healing of new blisters. Side effects were recorded when detected.

RESULTS: The % of improvement in the disease extent was statistically significantly higher (p = 0.009) in group I (mean ± SD: 59.21 ± 22.676) than in group II (mean ± SD: 44.03 ± 25.71). As regards the number of new blisters and the rate of healing of blisters, there was no statistically significant difference between both groups (p = 0.693 and 0.404, respectively). No serious side effects were reported.

CONCLUSION: MMF seems to be a good therapeutic option for the long-term treatment of EBD, it can be a good alternative for patients who cannot tolerate cyclosporine.

El-Darouti, M. A., M. M. Fawzy, I. M. Amin, R. M. Abdel Hay, R. A. HEGAZY, and D. M. ABDELHALIM, "Mycophenolate mofetil: a novel immunosuppressant in the treatment of dystrophic epidermolysis bullosa, a randomized controlled trial", Journal of Dermatological Treatment, vol. 24, no. 6: Taylor & Francis, pp. 422–426, 2013. Abstract
n/a
el Darouty, M. A., M. M. Fawzy, I. M. Amin, and R. M. mounir, "Mycophenolate mofetil: a novel immunosuppressant in the treatment of dystrophic epidermolysis bullosa, a randomized controlled trial", Journal of dermatological treatment, vol. 24, pp. 422-426, 2013. mofetil_in_eb_full.pdf
Hanafy, M. H., "Myconanotechnology in veterinary sector: Status quo and future perspectives.", International journal of veterinary science and medicine, vol. 6, issue 2, pp. 270-273, 2018 Dec. Abstractmyconanotechnology_in_veterinary_sector_status_quo.pdf

Nanotechnology is no longer a concept or a theory of the new world, it has turned into a new enabling technology over the years, with tremendous potential to revolutionize agriculture and livestock sector all over the globe. Moreover, nanotechnology provides new tools for molecular and cellular biology, biotechnology, veterinary physiology and reproduction, giving more promising solutions in both pathogen detection and therapy, engineering of agriculture, incredible results in animal and food systems and many more. Nanotechnology means manipulation, reduction and synthesis of materials at nano scale. Nanoparticles have distinct unique morphological characteristics which are quite different from their original bulk form. Recently, nanoparticles have been produced by industries for commercial applications having huge benefits. Since nanotechnology serves various fields of science and technology, the fabrication of nanoparticles using the biological route is becoming the need of the day. Biosynthesis of nanoparticles attracts the attentions of many researchers and industries to study microorganisms such as bacteria, fungi, algae and others as perfect biological factories for the fabrication of different nanoparticles. Among the different bionanofactories, the fungal system has emerged as an efficient most suitable system synthesizing metal nanoparticles by different mechanisms and for many reasons mentioned later. This review highlights the term "Myconanotechnology" in an attempt to direct more attention on fungi as a potential effective green approach in nanotechnology through conducting a SWOT analysis consisting of strengths, weaknesses, future opportunities of myconanosynthesis and probable constraints through eliciting questions for the possibility of using them in a large scale production.

Effat, K. G., and N. M. Madany, "Mycological study on cholesteatoma keratin obtained during primary mastoid surgery", The Journal of Laryngology & Otology, vol. 128, issue 10, pp. 881–884., 2014.
Ouf, S. A., "Mycological studies on the angiosperm root parasiteCynomorium coccineum L. and two of its halophytic hosts", Biologia plantarum, vol. 35, no. 4: Springer, pp. 591–602, 1993. Abstract
n/a
Ouf, S. A., "Mycoflora and population dynamics of some seedborne fungi in relation to the fungicide benlate", Zentralblatt für Mikrobiologie, vol. 148, no. 8: Urban & Fischer, pp. 570–581, 1993. Abstract
n/a
, "Mycobacterium bovis en bovinos y humanos.Capítulo 13. available under https://drive.google.com/file/d/1BXkmvNEk6-MYJxaVKYkC-J6s6cbWNG3Z/view", In ZOONOSIS Retos y oportunidades en el siglo XXI. EDITORES: Hugo Castañeda Vázquez · Martha Alicia Castañeda Vázquez Francisco Javier Padilla Ramírez · Oscar Carbajal Mariscal.: Primera edición digital, Mexico, ISBN: 9.786078.490837, 2020. Abstract
n/a
Tourism